'Global Biosimulation Market Worth Over $1.2 Billion in 2017' Says Visiongain Report
August 16, 2018
August 16, 2018
LONDON, England, Aug. 16 -- Visiongain, a independent media company, issued the following news release:
Visiongain's new report Biosimulation World Market 2017-2027 (https://www.visiongain.com/report/biosimulation-world-market-2017-2027/): Revenue Prospects by Product (PK/PD, Molecular, Toxicity, PBPK, Trial Design), Services (In-House, External), Application (Drug Development, Preclinical Testing, ADME/Tox, PK/PD, Clinical Trials, Drug Discovery, End User (Pharmaceutical and Biotec . . .
Visiongain's new report Biosimulation World Market 2017-2027 (https://www.visiongain.com/report/biosimulation-world-market-2017-2027/): Revenue Prospects by Product (PK/PD, Molecular, Toxicity, PBPK, Trial Design), Services (In-House, External), Application (Drug Development, Preclinical Testing, ADME/Tox, PK/PD, Clinical Trials, Drug Discovery, End User (Pharmaceutical and Biotec . . .